This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Astellas Pharma Gmbh, Kyoto University. Active years: 2011-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 425 
3 out of 872 
Years Active: 2011-2023
Title: Innovations in Renal Medicine: The Contributions of Inventor Yukiko Yamagishi
Introduction
Yukiko Yamagishi, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of regenerative medicine. With a total of five patents to her name, she has focused on developing innovative methods for producing renal progenitor cells, which hold promise in treating renal diseases.
Latest Patents
Among her latest patents, Yamagishi has developed a groundbreaking method for producing renal progenitor cells. This method allows for the acquisition and production of high-purity renal progenitor cells from a differentiated population of pluripotent stem cells. By identifying a specific cell surface antigen marker, her method enhances the utility of these cells in regenerative medicine, particularly for patients suffering from renal failure. Additionally, she has patented another method that involves producing renal progenitor cells from intermediate mesoderm cells. This method incorporates a culture medium containing TGF-β signaling activators and BMP inhibitors, resulting in renal progenitor cells that can form the basis for therapeutic drugs targeting kidney diseases.
Career Highlights
Throughout her career, Yukiko Yamagishi has worked with notable organizations including Astellas Pharma GmbH and Kyoto University. Her experience in these prestigious institutions has allowed her to push the boundaries of research and innovate in the rapidly evolving field of regenerative medicine.
Collaborations
Yamagishi has collaborated with esteemed colleagues such as Kenji Osafune and Masahiro Neya. Their partnerships have been instrumental in advancing her research and enhancing the impact of her inventions within the scientific community.
Conclusion
Yukiko Yamagishi's work exemplifies the critical role of inventors in the development of medical technologies. Her innovative methods for producing renal progenitor cells not only highlight her expertise but also contribute to the future of treatments for renal diseases. As she continues to advance her research, Yamagishi's contributions will undoubtedly leave a lasting impact on the field of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile